| ²é¿´: 1284 | »Ø¸´: 7 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
rbľ³æ (ÖøÃûдÊÖ)
С±¿³æ³æ
|
[½»Á÷]
¡¾×ªÔØ¡¿·ÖÏí¡¶×ªÈ¾¼¼ÊõÒªµã¼°×ªÈ¾ÊÔ¼ÁµÄÑ¡Ôñ¡·¡¾ÒÑËÑÎÞÖØ¸´¡¿
|
||
|
[watermark]תȾ¼¼ÊõÒªµã¼°×ªÈ¾ÊÔ¼ÁµÄÑ¡Ôñ תȾ¼¼ÊõÊÇÖ¸½«ÍâÔ´·Ö×ÓÈçDNA£¬RNAµÈµ¼ÈëÕæºËϸ°ûµÄ¼¼Êõ£¬ËüÊÇÑо¿»ùÒò±í´ïµ÷¿Ø£¬Í»±ä·ÖÎöµÈµÄ³£¹æ¹¤¾ß¡£Ëæ×ʦÄÜÑо¿µÄÐËÆð£¬ÆäÓ¦ÓÃÔ½À´Ô½¹ã·º¡£ÒÔϾÍÏò´ó¼Ò½éÉÜһЩתȾµÄ¼¼ÊõÒªµã¼°ÊÐÃæÉÏÖ÷ÒªµÄתȾÊÔ¼ÁÀàÐ͵ÄÑ¡Ôñ¡£ ³£¹æ×ªÈ¾¼¼Êõ¿É·ÖΪÁ½´óÀ࣬һÀàÊÇ˲ʱתȾ£¬Ò»ÀàÊÇÎȶ¨×ªÈ¾£¨ÓÀ¾ÃתȾ£©¡£Ç°ÕßÍâÔ´DNA/RNA²»ÕûºÏµ½ËÞÖ÷ȾɫÌåÖУ¬Òò´ËÒ»¸öËÞÖ÷ϸ°ûÖпɴæÔÚ¶à¸ö¿½±´Êý£¬²úÉú¸ßˮƽµÄ±í´ï£¬µ«Í¨³£Ö»³ÖÐø¼¸Ì죬¶àÓÃÓÚÆô¶¯×ÓºÍÆäËüµ÷¿ØÔª¼þµÄ·ÖÎö¡£Ò»°ãÀ´Ëµ£¬³¬ÂÝÐýÖÊÁ£DNAתȾЧÂʽϸߣ¬ÔÚתȾºó24-96СʱÄÚ£¨ÒÀÀµÓÚ¸÷ÖÖ²»Í¬µÄ¹¹½¨£©·ÖÎö½á¹û£¬³£³£Óõ½Ò»Ð©±¨¸æÏµÍ³ÈçÓ«¹âµ°°×£¬¦Â°ëÈéÌÇÜÕøµÈÀ´°ïÖú¼ì²â¡£ºóÕßÒ²³ÆÎȶ¨×ªÈ¾£¬ÍâÔ´DNA¼È¿ÉÒÔÕûºÏµ½ËÞÖ÷ȾɫÌåÖУ¬Ò²¿ÉÄÜ×÷ΪһÖÖÓÎÀëÌ壨episome£©´æÔÚ¡£¾¡¹ÜÏßÐÔDNA±È³¬ÂÝÐýDNAתÈëÁ¿µÍµ«ÕûºÏÂʸߡ£ÍâÔ´DNAÕûºÏµ½È¾É«ÌåÖиÅÂʺÜС£¬´óÔ¼1/104תȾϸ°ûÄÜÕûºÏ£¬Í¨³£ÐèҪͨ¹ýһЩѡÔñÐÔ±ê¼Ç£¬ÈçÀ´°±±û»ù×ªÒÆÃ¸£¨APH£»ÐÂÃ¹ËØ¿¹ÐÔ»ùÒò£©£¬³±Ã¹ËØBÁ×Ëá×ªÒÆÃ¸£¨HPH£©£¬ÐØÜÕ¼¤Ã¸£¨TK£©µÈ·´¸´É¸Ñ¡£¬µÃµ½Îȶ¨×ªÈ¾µÄͬԴϸ°ûϵ¡£ תȾЧÂÊÊÕ¶àÖÖÒòËØÓ°Ï죬Ö÷ÒªÒòËØÓÐÏÂÃæ¼¸¸ö£º 1. ϸ°ûÅàÑøÎï ½¡¿µµÄϸ°ûÅàÑøÎïÊdzɹ¦×ªÈ¾µÄ»ù´¡¡£²»Í¬Ï¸°ûÓв»Í¬µÄÅàÑø»ù£¬ÑªÇåºÍÌí¼ÓÎï¡£µÍµÄϸ°û´úÊý£¨<50£©ÄÜÈ·±£»ùÒòÐͲ»±ä¡£¸ßµÄתȾЧÂÊÐèÒªÒ»¶¨µÄϸ°ûÃܶȣ¬Ò»°ãµÄתȾÊÔ¼Á¶¼»áÓÐרÃŵÄ˵Ã÷¡£ÍƼöÔÚתȾǰ24Сʱ·Öϸ°û£¬Õ⽫ÌṩÕý³£Ï¸°û´úл£¬Ôö¼Ó¶ÔÍâÔ´DNAÉãÈëµÄ¿ÉÄÜ¡£Ò»¶¨Òª±ÜÃâϸ¾ú£¬Ö§ÔÌå»òÕæ¾úµÄÎÛȾ¡£ 2. ѪÇå ´ó¶àÊýÅàÑø»ùÔÚʹÓÃǰÐèÒª¼ÓѪÇ塣̥ţѪÇ壨FCS£©¾³£Óõ½£¬±ãÒËÒ»µãµÄÓÐÂí»òţѪÇ塣ͨ³£µÄ£¬ÑªÇåÊÇÒ»ÖÖ°üº¬Éú³¤Òò×Ó¼°ÆäËü¸¨ÖúÒò×ӵIJ»È·ÇгɷֵÄÌí¼ÓÎ¶Ô²»Í¬Ï¸°ûµÄÉú³¤×÷ÓÃÓкܴóµÄ²î±ð¡£ÑªÇåÖÊÁ¿µÄ±ä»¯Ö±½ÓÓ°ÏìתȾЧÂÊ¡£Òò´ËÔÚתȾǰ½¨ÒéÏȲâ(תÓÒ) ÊÔ³ö¶Ôϸ°ûÉú³¤Á¼ºÃµÄѪÇåÅúºÅ£¬×ªÈ¾Ê±ÓÃͬһÅúºÅµÄѪÇ壬²¢Í¬Ê±×ö¸º¶ÔÕÕ£¨²»¼ÓתȾÊÔ¼Á¼°ÍâÔ´DNA£©ÒÔ²âÊÔϸ°ûÉú³¤ÊÇ·ñÕý³£¡£ÓÐЩתȾ¼¼ÊõÈçÖ¬ÖÊÌåתȾÔÚÓÐѪÇå´æÔÚÇé¿öÏÂЧÂʺܵͣ¬Òò´ËÔÚתȾǰҪ³ýѪÇå¡£µ«ÓÐЩ¶Ô´ËÃô¸ÐµÄϸ°ûÈçÔ´úϸ°û»áÊܵ½ËðÉË£¬ÉõÖÁËÀÍöµ¼ÖÂתȾЧÂʼ«µÍ¡£ 3. ÔØÌå¹¹½¨ ×ªÈ¾ÔØÌåµÄ¹¹½¨£¨²¡¶¾ÔØÌ壬ÖÊÁ£DNA£¬RNA£¬PCR²úÎ¹ÑºËÜÕËáµÈ£©Ò²Ó°ÏìתȾ½á¹û¡£²¡¶¾ÔØÌå¶ÔÌØ¶¨ËÞÖ÷ϸ°û¸ÐȾЧÂʽϸߣ¬µ«²»Í¬²¡¶¾ÔØÌåÓÐÆäÌØ¶¨µÄËÞÖ÷£¬ÓеĻ¹ÒªÇóÌØ¶¨µÄϸ°ûÖÜÆÚ£¬ÈçÄæ×ªÂ¼²¡¶¾ÐèÇÖȾ·ÖÁÑÆÚµÄËÞÖ÷ϸ°û£¬´ËÍ⻹Ð迼ÂÇһЩ°²È«ÎÊÌ⣨Èç»ùÒòÎÛȾ£©¡£³ýÔØÌå¹¹½¨Íâ£¬ÔØÌåµÄÐÎ̬¼°´óС¶ÔתȾЧÂÊÒ²Óв»Í¬µÄÓ°Ï죬ÈçÇ°ÃæÌáµ½µÄ³¬ÂÝÐý¼°ÏßÐÔDNA¶Ô˲ʱºÍÎȶ¨×ªÈ¾µÄÓ°Ïì¡£Èç¹û»ùÒò²úÎï¶Ôϸ°ûÓж¾ÐÔ×÷Óã¬×ªÈ¾Ò²ºÜÄѽøÐУ¬Òò´ËÑ¡Ôñ×é³É»ò¿Éµ÷¿Ø£¬Ç¿¶ÈºÏÊÊµÄÆô¶¯×ÓÒ²ºÜÖØÒª£¬Í¬Ê±×ö¿ÕÔØÌå¼°ÆäËü»ùÒòµÄÏàÍ¬ÔØÌå¹¹½¨µÄתȾÕý¶ÔÕÕ¿ÉÅųý¶¾ÐÔÓ°ÏìµÄ¸ÉÈÅ¡£ 4. DNAÖÊÁ¿ DNAÖÊÁ¿¶ÔתȾЧÂÊÓ°Ïì·Ç³£´ó¡£Ò»°ãµÄתȾ¼¼Êõ£¨ÈçÖ¬ÖÊÌåµÈ£©»ùÓÚµçºÉÎüÒýÔÀí£¬Èç¹ûDNA²»´¿£¬Èç´øÉÙÁ¿µÄÑÎÀë×Ó£¬µ°°×£¬´úлÎïÎÛȾ¶¼»áÏÔÖøÓ°ÏìתȾ¸´ºÏÎïµÄÓÐЧÐγɼ°×ªÈ¾µÄ½øÐС£ºËËá´¿»¯ÊÀ½çµÚÒ»Æ·ÅÆµÂ¹úQIAGEN¹«Ë¾ÌṩµÄ³¬´¿ÖÊÁ£³éÌáÊÔ¼ÁºÐ£¬ÄÜ´ïµ½Á½±¶2x CsClÌݶÈÀëÐÄÒÔÉϵĴ¿¶ÈЧ¹û£¬Ê¹Äú²»±ØÎªDNAÖÊÁ¿²ÙÐÄ¡£´ËÍ⣬¶ÔһЩÄÚ¶¾ËØÃô¸ÐµÄϸ°û£¨ÈçÔ´úϸ°û£¬Ðü¸¡Ï¸°ûºÍÔìѪϸ°û£©£¬QIAGEN»¹Ìṩ¿ÉÈ¥³ýÄÚ¶¾ËØÎÛȾµÄÖÊÁ£³éÌáÊÔ¼ÁºÐ£¬ÔÚÖÊÁ£³éÌá¹ý³ÌÖÐÓÐЧȥ³ýÖ¬¶àÌÇ·Ö×Ó£¬±£Ö¤ÀíÏëµÄתȾЧ¹û¡£ 5.תȾ¼¼Êõ תȾ¼¼ÊõµÄÑ¡Ôñ¶ÔתȾ½á¹ûÓ°ÏìÒ²ºÜ´ó£¬Ðí¶àתȾ·½·¨ÐèÒªÓÅ»¯DNAÓëתȾÊÔ¼Á±ÈÀý£¬Ï¸°ûÊýÁ¿£¬ÅàÑø¼°¼ì²âʱ¼äµÈ¡£Ò»Ð©´«Í³µÄתȾ¼¼Êõ£¬ÈçDEAEÓÒÐýÌÇÜÕ·¨£¬Á×Ëá¸Æ·¨£¬µç´©¿×·¨£¬Ö¬ÖÊÌå·¨¸÷ÓÐÀû±×£¬ÆäÖ÷ÒªÔÀí¼°Ó¦ÓÃÌØµã¼ûÏ£º תȾ·½·¨ ÔÀí Ó¦ÓÃ ÌØµã DEAE-ÓÒÐýÌÇÜÕ·¨ ´øÕýµçµÄDEAE-ÓÒÐýÌÇÜÕÓëºËËá´ø¸ºµçµÄÁ×Ëá¹Ç¼ÜÏ໥×÷ÓÃÐγɵĸ´ºÏÎﱻϸ°ûÄÚÍÌ Ë²Ê±ÐÔתȾ Ïà¶Ô¼ò±ã¡¢½á¹û¿ÉÖØ¸´ µ«¶Ôϸ°ûÓÐÒ»¶¨µÄ¶¾¸±×÷Óà תȾʱÐè³ýѪÇå Á×Ëá¸Æ·¨ Á×Ëá¸ÆDNA¸´ºÏÎïÎü¸½Ï¸°ûĤ±»Ï¸°ûÄÚÍÌ Îȶ¨×ªÈ¾ ˲ʱÐÔתȾ ²»ÊÊÓÃÓÚÔ´úϸ°û ²Ù×÷¼ò±ãµ«Öظ´ÐÔ²î ÓÐЩϸ°û²»ÊÊÓà µç´©¿×·¨ ¸ßÂö³åµçÑ¹ÆÆ»µÏ¸°ûĤµç룬DNAͨ¹ýĤÉÏÐγɵÄС¿×µ¼Èë Îȶ¨×ªÈ¾ ˲ʱÐÔתȾ ËùÓÐϸ°û ÊÊÓÃÐԹ㵫ϸ°ûÖÂËÀÂʸߣ¬DNAºÍϸ°ûÓÃÁ¿´ó£¬ Ðè¸ù¾Ý²»Í¬Ï¸°ûÀàÐÍÓÅ»¯µç´©¿×ʵÑéÌõ¼þ ÑôÀë×ÓÐÔµÄÖ¬ÖÊÌå·¨ ´øÕýµçµÄÖ¬ÖÊÌåÓëºËËá´ø¸ºµçµÄÁ×Ëá»ùÍÅÐγɸ´ºÏÎﱻϸ°ûÄÚÍÌ Îȶ¨×ªÈ¾ ˲ʱÐÔתȾ ËùÓÐϸ°û ÊÊÓÃÐԹ㣬תȾЧÂʸߣ¬ ÖØ¸´ÐԺõ«×ªÈ¾Ê±Ðè³ýѪÇå תȾЧ¹ûËæÏ¸°ûÀàÐͱ仯´ó ²¡¶¾½éµ¼·¨ Äæ×ªÂ¼²¡¶¾ ͨ¹ýÇÖȾËÞÖ÷ϸ°û½«ÍâÔ´»ùÒòÕûºÏµ½È¾É«ÌåÖÐ Îȶ¨×ªÈ¾ ÌØ¶¨ËÞÖ÷ϸ°û ¿ÉÓÃÓÚÄÑתȾµÄϸ°û¡¢Ô´úϸ°û£¬ÌåÄÚϸ°ûµÈ µ«Ð¯´ø»ùÒò²»ÄÜÌ«´ó ϸ°ûÐè´¦·ÖÁÑÆÚ Ð迼Âǰ²È«ÒòËØ ÏÙ²¡¶¾ ˲ʱתȾ ÌØ¶¨ËÞÖ÷ϸ°û ¿ÉÓÃÓÚÄÑתȾµÄϸ°û Ð迼Âǰ²È«ÒòËØ Biolistic ¿ÅÁ£´«µÝ·¨ ½«DNAÓÃÏÔÎ¢ÖØ½ðÊô¿ÅÁ£³Áµí£¬ÔÙ½«°ü±»ºÃµÄ¿ÅÁ£Óõ¯µÀ×°ÖÃͶÉäÈëϸ°û£¬DNAÔÚ°ûÄÚÖð²½ÊÍ·Å£¬±í´ï ˲ʱÐÔתȾ ¿ÉÓÃÓÚ£ºÈËµÄ±íÆ¤Ï¸°û£¬ÏËάÔϸ°û£¬ÁܰÍϸ°ûϵÒÔ¼°Ô´úϸ°û ÏÔ΢עÉä·¨ ÓÃÏÔ΢²Ù×÷½«DNAÖ±½Ó×¢Èë°Ðϸ°ûºË Îȶ¨×ªÈ¾ ˲ʱÐÔתȾ תȾϸ°ûÊýÓÐÏÞ ¶àÓÃÓÚ¹¤³Ì¸ÄÔì»òת»ùÒò¶¯ÎïµÄÅß̥ϸ°û Plasmid Purification Methods vs.Transfection Efficiency ͼ1. Primary rabbit gastric parietal cells were transfected with a GFP reporter plasmid prepared using the methods indicated. Transfections were performed using Effectene Reagent or a commonly used liposome reagent (Liposome C). The bars represent the percentage of total cells expressing GFP as determined by scoring the number of green fluorescent cells 48 h post-transfection. Data represent the average of 6¨C9 replicate dishes using more than 2 different DNA preparations for each purification method. Data kindly provided by J. Parente and C. Chew, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA, USA. Plasmid Purity and Quantity vs.Transfection Efficiency ͼ2.Effect of the amount and quality of DNA (a luciferase reporter plasmid) on transfection efficiency in CHO SSF variants grown in suspension under serum-free conditions. Each point represents the mean of three independent experiments; bars represent standard deviations; Rel. LU: relative light units. Data kindly provided by M. O. Zang-Gandor, Novartis AG, Basel, Switzerland. ¡¡ ³ýÉÏÊö´«Í³·½·¨Í⣬µÂ¹úQIAGEN¹«Ë¾½üÄêÍÆ³öÁ˼¸ÖÖ¸ïеļ¼Êõ£¬ÒÔÆäÊÊÓÃËÞÖ÷·¶Î§¹ã£¬²Ù×÷¼ò±ã£¬¶Ôϸ°û¶¾ÐÔС£¬×ªÈ¾Ð§ÂʸßÊܵ½Ñо¿ÕßÃǵÄÇàíù¡£¾ßÌ嵨·ÖÒÔϼ¸ÖÖ£º 1. »îÐÔdendrimers£ºSuperfect Transfection Reagent Dendrimers ÊÇÒ»¸ö¸ß¶È·ÖÖ¦µÄÇòÐηÖ×Ó£¬·ÖÖ¦´ÓÇòÐÄ·ÅÉä×´·¢³ö£¬ÖÕÖ¹ÓÚ´øµçºÉµÄ°±»ù¼¯ÍÅ¡£ÓÉÓÚËüÊÇ»¯Ñ§ºÏ³ÉµÄ£¬Óо«È·µÄ´óСºÍÐÎ×´£¬±£Ö¤Ò»ÖµÄתȾ¸´ºÏÎïÐγɺÍתȾµÄÖØ¸´ÐÔ¡£²¿·ÖµØ»îÐÔ¸ÄÔìʹËü¾ßÓиü¸ßµÄµ¯ÐÔ£¨¼ûͼ1£©Í¬Ñù£¬ÓÃËüתȾʱҲ²»ÓóýѪÇ壬¶Ôϸ°û¶¾ÐÔС£¬×ªÈ¾Ð§Âʸߡ£ Schematic diagram of an activated and non-activated dendrimer. A portion of the activated dendrimer molecule is enlarged to show the chemical structure of the molecular branches. ͼ3 Dendrimers½á¹¹Ê¾Òâͼ ¡¡ 2. רÃÅΪ³£ÓÃϸ°ûÓÅ»¯µÄ¨DPolyfect Transfection Reagent QIAGEN»¹×¨ÃÅΪʵÑéÊÒ³£ÓÃϸ°û£ºCOS-7£¬NIH/3T3£¬HeLa£¬293£¬CHOÓÅ»¯Éè¼ÆÁË»ùÓÚ»îÐÔdendrimers¼¼ÊõµÄPolyfect transfection reagent£¬²Ù×÷¸ü¼Ó¼ò±ã£¬¶øÇÒ¼Û¸ñ¾¼Ã¡£ ¡¡ 3. ¸ÄÁ¼µÄÖ¬ÀàתȾÊÔ¼Á¨DEffectene transfection reagent ³ýÁËÔÚÖ¬ÀàµÄ½á¹¹ÉÏÓÐËù¸Ä½øÍ⣬Ëü»¹ÔöÌíÁËÔöÇ¿·Ö×Ó£¨Enhancer molecular£©½«DNAŨËõºóÓëתȾÊÔ¼Á·´Ó¦£¨¼ûͼ2£©£¬²»½öתȾЧÂʸߣ¬»¹´ó´ó½ÚÊ¡ÁËDNAÓÃÁ¿£¨Ö»ÐèÒ»°ãÖ¬ÖÊÌåµÄ1/5£©¡£´ËÍ⣬ÓëÒ»°ãÖ¬ÖÊÌåÏà±È£¬ËüÔÚתȾʱÎÞÐè³ýѪÇ壬¼È¼ò»¯Á˲Ù×÷£¬¸üÌá¸ßÁ˶ÔѪÇåÃô¸ÐµÄÔ´úϸ°ûµÈµÄתȾЧÂÊ¡££¨¼ûͼ£³£áºÍ£â²Ù×÷Á÷³Ì±È½Ï£©¡£ ͼ3.A Liposome-Mediated Transfection ¡¡ ͼ3.B Effectene procedure ¡¡ 4. ×îÐÂתRNAµÄ¨DTransmessenger transfection reagent RNAתȾ²»ÒÀÀµÆô¶¯×Ó£¬ÎÞÐèת¼ֱ½Ó±í´ï¹¦Äܵ°°×£¬ÊDz»Í¬ÓÚDNAתȾµÄÁíÒ»ÖÖ˼·£¬ÓÈÆä¶ÔÖÊÁ£DNAתȾÀ§ÄѵÄÇé¿öϸüÊÇÒ»¸öºÃ·½·¨¡£´ËÍâRNAתȾ»¹¿ÉÒÔÓÃ×÷RNA²¡¶¾£¬RNA·ÒëÑо¿¼°RNA¸ÉÈÅ£¨RNAi£©ÊµÑé¡£»ùÓÚ¸ÄÁ¼Ö¬À༼ÊõµÄתȾÊÔ¼ÁTransmessenger transfection reagentÊÇ×îÐÂÍÆ³öµÄרÃÅÊÊÓÃÓÚת¸÷ÖÖRNAµÄתȾÊÔ¼Á£¬ÅäÓÐŨËõRNAµÄÔöÇ¿·Ö×Ó£¬ÎÞRNAøÎÛȾ£¬²Ù×÷·½±ã£¬×ªÈ¾Ð§Âʸߡ££¨¼ûÁ÷³Ìͼͼ£´¼°×ªÈ¾Ð§¹ûͼͼ£µ£© ¡¡ ´ËÍ⣬QIAGENÍøwww.QIAGEN.com/transfectiontoolsÌṩËüµÄËùÓÐתȾÊÔ¼ÁµÄÊÊÓÃϸ°ûÖê¼°·¢±íÎÄÏ×µÄÔÚÏß²éѯ£¬ÒÔ±ã¹ã´óÓû§¸ü¿ì¸üÓÐЧµØÑ¡ÔñºÏÊʵÄתȾÊÔ¼Á¼°Éè¼Æ×ªÈ¾ÊµÑé¡£ÎÒÃǽ«¼ÌÐø×·×ÙÕâ·½ÃæµÄм¼Êõ¼°Ó¦Óþ¡¿ìÌṩ¸ø´ó¼Ò¡£ ͼ5 Western blots of transfected HeLa-S3 cell extracts using lamin A/C- or vimentin-specific monoclonal antibodies. Cells were transfected using the indicated reagents. TM: TransMessenger Transfection Reagent; siRNA; short interfering RNA; ODN: scrambled 24mer oligodeoxynucleotide. A Lamin A/C expression was significantly reduced in cells that had been transfected with TransMessenger Reagent-siRNA complexes. B Expression was not suppressed in cells that were untransfected, transfected using TransMessenger Reagent or siRNA alone, or transfected with a scrambled ODN¨CTransMessenger Reagent complex.[/watermark] [ Last edited by zhoukoulk on 2008-11-24 at 14:49 ] |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ3È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼ÓÖдÓʼþÁË£¬Ã»»Ø¸´
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧ˶318Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
081700»¯¹¤Ñ§Ë¶µ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

someso
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 2.5
- ½ð±Ò: 2341.4
- Ìû×Ó: 315
- ÔÚÏß: 36.9Сʱ
- ³æºÅ: 21368
- ×¢²á: 2003-08-25
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

4Â¥2004-02-13 21:35:13
wwangfeng
Òø³æ (ÕýʽдÊÖ)
³Ïʵ×öÈË̤ʵ×öÊÂ
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 4.55
- ½ð±Ò: 480.7
- ºì»¨: 1
- Ìû×Ó: 624
- ÔÚÏß: 47.9Сʱ
- ³æºÅ: 6058
- ×¢²á: 2003-04-05
- ÐÔ±ð: GG
- רҵ: ¸ÎÏËά»¯¡¢¸ÎÓ²»¯ÓëÃÅÂö¸ß

2Â¥2004-02-13 20:04:43
rb
ľ³æ (ÖøÃûдÊÖ)
С±¿³æ³æ
- Ó¦Öú: 44 (СѧÉú)
- ¹ó±ö: 0.1
- ½ð±Ò: 4952.8
- É¢½ð: 1634
- ºì»¨: 8
- Ìû×Ó: 2357
- ÔÚÏß: 285.2Сʱ
- ³æºÅ: 30311
- ×¢²á: 2003-11-30
- ÐÔ±ð: GG
- רҵ: ÈËÀàÒÅ´«Ñ§

3Â¥2004-02-13 21:05:21
rb
ľ³æ (ÖøÃûдÊÖ)
С±¿³æ³æ
- Ó¦Öú: 44 (СѧÉú)
- ¹ó±ö: 0.1
- ½ð±Ò: 4952.8
- É¢½ð: 1634
- ºì»¨: 8
- Ìû×Ó: 2357
- ÔÚÏß: 285.2Сʱ
- ³æºÅ: 30311
- ×¢²á: 2003-11-30
- ÐÔ±ð: GG
- רҵ: ÈËÀàÒÅ´«Ñ§

5Â¥2004-02-13 22:36:02













»Ø¸´´ËÂ¥
